These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 30013791)

  • 21. Diabetes management in older adults who fall: a study amongst older adults presenting to the emergency department.
    Burgess AJ; Williams DM; Collins K; Roberts R; Burberry DJ; Stephens JW; Davies EA
    Eur Geriatr Med; 2023 Oct; 14(5):1105-1110. PubMed ID: 37612537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative cardiovascular and hypoglycaemic safety of glimepiride in type 2 diabetes: A population-based cohort study.
    Douros A; Dell'Aniello S; Yu OHY; Suissa S
    Diabetes Obes Metab; 2020 Feb; 22(2):254-262. PubMed ID: 31596043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug Interactions of Clinical Importance with Antihyperglycaemic Agents : An Update.
    Scheen AJ
    Drug Saf; 2005 Jul; 28(7):601-631. PubMed ID: 27722966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
    Choudhary P; Lonnen K; Emery CJ; MacDonald IA; MacLeod KM; Amiel SA; Heller SR
    Diabet Med; 2009 Jul; 26(7):665-72. PubMed ID: 19573114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).
    Zinman B; Marso SP; Poulter NR; Emerson SS; Pieber TR; Pratley RE; Lange M; Brown-Frandsen K; Moses A; Ocampo Francisco AM; Barner Lekdorf J; Kvist K; Buse JB;
    Diabetologia; 2018 Jan; 61(1):48-57. PubMed ID: 28913575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Patient-level Analysis of Efficacy and Hypoglycaemia Outcomes Across Treat-to-target Trials with Insulin Glargine Added to Oral Antidiabetes Agents in People with Type 2 Diabetes.
    DeVries JH; Meneghini L; Barnett AH; Reid T; Dain MP; Landgraf W; Vlajnic A; Traylor L; Bergenstal RM
    Eur Endocrinol; 2014 Feb; 10(1):23-30. PubMed ID: 29872460
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
    Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug interactions of clinical importance with antihyperglycaemic agents: an update.
    Scheen AJ
    Drug Saf; 2005; 28(7):601-31. PubMed ID: 15963007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor-1alpha gene mutations: evidence for pharmacogenetics in diabetes.
    Pearson ER; Liddell WG; Shepherd M; Corrall RJ; Hattersley AT
    Diabet Med; 2000 Jul; 17(7):543-5. PubMed ID: 10972586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental non-severe hypoglycaemia substantially impairs cognitive function in type 2 diabetes: a randomised crossover trial.
    Nilsson M; Jensen N; Gejl M; Bergmann ML; Storgaard H; Zander M; Miskowiak K; Rungby J
    Diabetologia; 2019 Oct; 62(10):1948-1958. PubMed ID: 31367958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.
    Fullerton B; Siebenhofer A; Jeitler K; Horvath K; Semlitsch T; Berghold A; Plank J; Pieber TR; Gerlach FM
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD012161. PubMed ID: 27362975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative tolerability profiles of oral antidiabetic agents.
    Krentz AJ; Ferner RE; Bailey CJ
    Drug Saf; 1994 Oct; 11(4):223-41. PubMed ID: 7848543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of prandial glucose regulation with repaglinide: a solution to the problem of hypoglycaemia in the treatment of Type 2 diabetes?
    Nattrass M; Lauritzen T
    Int J Obes Relat Metab Disord; 2000 Sep; 24 Suppl 3():S21-31. PubMed ID: 11063281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A retrospective observational study of people with Type 1 diabetes with self-reported severe hypoglycaemia reveals high level of ambulance attendance but low levels of therapy change and specialist intervention.
    Field BCT; Nayar R; Kilvert A; Baxter M; Hickey J; Cummings M; Bain SC
    Diabet Med; 2018 May; ():. PubMed ID: 29766565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between dementia and the risk of hypoglycaemia events among patients with diabetes mellitus: a propensity-score matched cohort analysis.
    Alsharif AA; Wong ICK; Ma T; Lau W; Alhamed M; Alwafi H; Wei L
    Front Med (Lausanne); 2023; 10():1177636. PubMed ID: 37476614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of drugs on hypoglycaemia in hospitalised patients.
    Vandenberghe F; Challet C; Maitrejean M; Christin L; Schaad N
    Eur J Hosp Pharm; 2019 Jul; 26(4):199-204. PubMed ID: 31338167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment and prevention of hypoglycaemia in primary care among U.S. Veterans: a mixed methods study.
    Pilla SJ; Meza KA; Beach MC; Long JA; Gordon HS; Bates JT; Washington DL; Bokhour BG; Tuepker A; Saha S; Maruthur NM
    Lancet Reg Health Am; 2023 Dec; 28():100641. PubMed ID: 38076413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Diabetes Medication Therapy Adherence Clinic (DMTAC) appointment intervals on glycemic control in public health clinics across Perak, Malaysia.
    Beh YS; Gopalsamy K; Lee SLF; P Vengadasalam VP
    Malays Fam Physician; 2022 Nov; 17(3):105-113. PubMed ID: 36606164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HbA1c and hypoglycaemia in intensively treated type 2 diabetes: a retrospective cohort study in primary care.
    Malawana M; Kerry S; Mathur R; Robson J
    JRSM Open; 2018 Jul; 9(7):2054270418773669. PubMed ID: 30013791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethnic variations in the risk of hypoglycaemia among people with Type 2 diabetes prescribed insulins and/or sulfonylureas: a historical cohort study using general practice-recorded data.
    Malawana M; Hutchings A; Mathur R; Robson J
    Diabet Med; 2018 Dec; 35(12):1707-1715. PubMed ID: 30264528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.